Emed News Tuesday, April 15, 2008   New Treatments to Fight Liver, Colon Cancer A new drug pair may assist defending colorectal cancer, and the influential new cancer drug Sutent might also slow the succession of liver cancer. So conclude two studies presented Monday at the American Association for Cancer Research annual meeting in San Diego. In the first study, researchers found that a two-drug routine made up of low doses of difluoromethylornithine (DFMO) plus sulindac, a non-steroidal anti-inflammatory drug (NSAID), lessen the risk of colorectal adenomas by up to 95 percent. Colorectal adenomas are a near the beginning sign of colon cancer.   posted by emedinfo @12:54 AM permanent link   | |    Bookmark & Share     << Home

Previous Posts Alcohol drinking women can develop breast cancer Non-Hodgkin Lymphoma Cancer danger in the midst of youthful via sunbeds Lung cancer cause is discovered Kidney (Renal Cell) Cancer Bladder Cancer Cervical Cancer 108 women died of faulty breast cancer tests Greater Risk of Caner for Fat Lady Scientists exposes 'master' breast cancer gene